We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

142 hedge funds and large institutions have $760M invested in OptimizeRx in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

114% more call options, than puts

Call options by funds: $55.2M | Put options by funds: $25.8M

34% more capital invested

Capital invested by funds: $567M → $760M (+$192M)

17% more funds holding

Funds holding: 121 → 142 (+21)

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

2.18% more ownership

Funds ownership: 68.96% → 71.14% (+2.2%)

Holders
142
Holders Change
+21
Holders Change %
+17.36%
% of All Funds
2.47%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
39
Increased
45
Reduced
40
Closed
18
Calls
$55.2M
Puts
$25.8M
Net Calls
+$29.4M
Net Calls Change
-$4.32M

Top Buyers

1
PCA
Prospect Capital Advisors
California
+$15.6M
2
DCM
Driehaus Capital Management
Illinois
+$6.18M
3
LCG
Lisanti Capital Growth
New York
+$5.21M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.39M
5
FLAM
First Light Asset Management
Minnesota
+$3.59M

Top Sellers

1
MS
Maven Securities
Jersey
-$5.73M
2
Marshall Wace
Marshall Wace
United Kingdom
-$5.11M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.84M
4
GIPM
G2 Investment Partners Management
New York
-$3.02M
5
NCGI
Next Century Growth Investors
Minnesota
-$2.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
101
TownSquare Capital
Utah
$312K +$271K +5,327 New
ProShare Advisors
102
ProShare Advisors
Maryland
$271K +$458 +9 +0.2%
AQR Capital Management
103
AQR Capital Management
Connecticut
$269K -$19.4K -382 -8%
PP
104
PDT Partners
New York
$264K +$217K +4,269 New
ASRS
105
Arizona State Retirement System
Arizona
$251K +$206K +4,048 New
UBS Group
106
UBS Group
Switzerland
$250K +$137K +2,686 +198%
IAA
107
Independent Advisor Alliance
North Carolina
$243K +$200K +3,931 New
Principal Financial Group
108
Principal Financial Group
Iowa
$240K +$197K +3,880 New
VIA
109
Vident Investment Advisory
Georgia
$228K +$187K +3,676 New
Citigroup
110
Citigroup
New York
$213K +$120K +2,360 +219%
JCM
111
Jacobi Capital Management
Pennsylvania
$213K +$140K +2,749 +393%
FFA
112
First Foundation Advisors
California
$206K +$170K +3,334 New
LPL Financial
113
LPL Financial
California
$204K +$168K +3,303 New
Barclays
114
Barclays
United Kingdom
$188K -$539K -10,599 -78%
Legal & General Group
115
Legal & General Group
United Kingdom
$180K +$58.3K +1,145 +64%
DWA
116
Dorsey Wright & Associates
California
$106K – – –
AIP
117
Ameritas Investment Partners
Nebraska
$78K – – –
PHK
118
Point72 Hong Kong
Hong Kong
$70K +$57.5K +1,129 New
HWM
119
HighMark Wealth Management
Minnesota
$62K +$49K +963 +2,189%
OSAM
120
O'Shaughnessy Asset Management
Connecticut
$44K – – –
Bessemer Group
121
Bessemer Group
New Jersey
$37K -$33.8K -665 -53%
TRCT
122
Tower Research Capital (TRC)
New York
$37K -$24.3K -478 -45%
CG
123
Cutler Group
California
$36K -$75.4K -1,481 -72%
BNP Paribas Financial Markets
124
BNP Paribas Financial Markets
France
$34.9K -$76.6K -1,506 -73%
CAPTRUST Financial Advisors
125
CAPTRUST Financial Advisors
North Carolina
$20K +$967 +19 +6%
3 4
5
6 7

OPRX Hedge Fund Activity: Q2 2021 in Review

142 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2021, worth a combined $760M — up 34% from $567M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new OPRX positions and 18 closed out — a net gain of 21 holders — while 45 added to existing stakes and 40 trimmed.

The largest buyer was Prospect Capital Advisors, opening a new position worth an estimated $15.6M. The largest seller was Maven Securities, cutting an estimated $5.73M.

  • 142 institutional investors held OptimizeRx (OPRX) as of Q2 2021, up from 121 in Q1 2021.
  • Funds reported $760M of OptimizeRx stock for Q2 2021, up 34% quarter-over-quarter.
  • 39 funds opened new OptimizeRx positions in Q2 2021 and 18 closed out, a net change of +21 holders.
  • The largest OptimizeRx buyer in Q2 2021 was Prospect Capital Advisors, an estimated $15.6M added.
  • The largest OptimizeRx seller in Q2 2021 was Maven Securities, an estimated $5.73M sold.

Based on aggregated 13F filings for Q2 2021.